Screener
Aclaris Therapeutics ACRS Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Aclaris Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Aclaris Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-092065
FAQ
- What is Aclaris Therapeutics's net income?
- Aclaris Therapeutics (ACRS) reported net income of -$21.51M in Q2 2026.
- How has Aclaris Therapeutics's net income changed year-over-year?
- Aclaris Therapeutics's net income decreased by 39.4% year-over-year, from -$15.43M to -$21.51M.
- What is the long-term trend for Aclaris Therapeutics's net income?
- Over 4 years (2021 to 2025), Aclaris Therapeutics's net income has grown at a -8.1% compound annual growth rate (CAGR), from -$90.87M to -$64.92M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Aclaris Therapeutics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude